News

Morningstar20d
SNS812, an innovative siRNA drug from Oneness and Microbio (Shanghai), selected for ATS 2025 oral presentation, demonstrating world-leading clinical outcomes in COVID-19 treatment
and expanding siRNA applications across major infectious diseases and global public health challenges—bringing transformative solutions to human health. Oneness Biotech Co., Ltd. is a ...
Fox2Now St. Louis1mon
Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
application for RN1871, a small interfering RNA (siRNA) drug targeting angiotensinogen (AGT), has been approved by China's National Medical Products Administration (NMPA). RN1871 is designed to ...
Taiwan News20d
SNS812, an innovative siRNA drug from Oneness and Microbio (Shanghai), selected for ATS 2025 oral presentation, demonstrating world-leading clinical outcomes in COVID-19 treatment
Oneness Biotech and Microbio (Shanghai) continue to advance the global clinical development and licensing collaborations for SNS812, accelerating its path to commercialization, and expanding siRNA ...